• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚合物的胰高血糖素样肽-1递送用于糖尿病治疗

Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.

作者信息

Kim Pyung-Hwan, Kim Sung Wan

机构信息

Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.

出版信息

ISRN Endocrinol. 2012;2012:340632. doi: 10.5402/2012/340632. Epub 2012 May 30.

DOI:10.5402/2012/340632
PMID:22701182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3369441/
Abstract

The incretin hormones, glucagon-like peptide-1 (GLP-1) and its receptor agonist (exendin-4), are well known for glucose homeostasis, insulinotropic effect, and effects on weight loss and food intake. However, due to the rapid degradation of GLP-1 by dipeptidylpeptidase-IV (DPP-IV) enzyme and renal elimination of exendin-4, their clinical applications have been restricted. Although exendin-4 has longer half-life than GLP-1, it still requires frequent injections to maintain efficacy for the treatment of diabetes. In recent decades, various polymeric delivery systems have been developed for the delivery of GLP-1 and exendin-4 genes or peptides for their long-term action and the extra production in ectopic tissues. Herein, we discuss the modification of the expression cassettes and peptides for long-term production and secretion of the native peptides. In addition, the characteristics of nonviral or viral system used for a delivery of a modified GLP-1 or exendin-4 are described. Furthermore, recent efforts to improve the biological half-life of GLP-1 or exendin-4 peptide via chemical conjugation with various smart polymers via chemical conjugation compared with native peptide are discussed.

摘要

肠促胰岛素激素,胰高血糖素样肽-1(GLP-1)及其受体激动剂(艾塞那肽-4),以其在葡萄糖稳态、促胰岛素分泌作用以及对体重减轻和食物摄入的影响而闻名。然而,由于二肽基肽酶-IV(DPP-IV)酶可使GLP-1迅速降解,且艾塞那肽-4经肾脏排泄,它们的临床应用受到了限制。尽管艾塞那肽-4的半衰期比GLP-1长,但仍需要频繁注射以维持治疗糖尿病的疗效。近几十年来,已开发出各种聚合物递送系统来递送GLP-1和艾塞那肽-4基因或肽,以实现其长期作用和在异位组织中的额外产生。在此,我们讨论了表达盒和肽的修饰,以实现天然肽的长期产生和分泌。此外,还描述了用于递送修饰后的GLP-1或艾塞那肽-4的非病毒或病毒系统的特性。此外,还讨论了与天然肽相比,近期通过与各种智能聚合物进行化学偶联来提高GLP-1或艾塞那肽-4肽生物半衰期的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb6/3369441/8ab4ef2506df/ISRN.ENDOCRINOLOGY2012-340632.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb6/3369441/0178ebbdefd0/ISRN.ENDOCRINOLOGY2012-340632.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb6/3369441/8ab4ef2506df/ISRN.ENDOCRINOLOGY2012-340632.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb6/3369441/0178ebbdefd0/ISRN.ENDOCRINOLOGY2012-340632.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb6/3369441/8ab4ef2506df/ISRN.ENDOCRINOLOGY2012-340632.002.jpg

相似文献

1
Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.基于聚合物的胰高血糖素样肽-1递送用于糖尿病治疗
ISRN Endocrinol. 2012;2012:340632. doi: 10.5402/2012/340632. Epub 2012 May 30.
2
Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model.用 Arg 修饰的生物可还原聚合物递呈两步转录扩增 Exendin-4 质粒系统在 2 型糖尿病动物模型中的应用。
J Control Release. 2012 Aug 20;162(1):9-18. doi: 10.1016/j.jconrel.2012.06.010. Epub 2012 Jun 15.
3
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).胰高血糖素样肽-1(7-36)酰胺中赖氨酸9被谷氨酸9取代可赋予二肽基肽酶IV抗性,其细胞和代谢作用类似于已有的拮抗剂胰高血糖素样肽-1(9-36)酰胺和艾塞那肽(9-39)。
Metabolism. 2004 Feb;53(2):252-9. doi: 10.1016/j.metabol.2003.09.015.
4
Enhancing incretin action for the treatment of type 2 diabetes.增强肠促胰岛素作用以治疗2型糖尿病。
Diabetes Care. 2003 Oct;26(10):2929-40. doi: 10.2337/diacare.26.10.2929.
5
Properties of native and in vitro glycosylated forms of the glucagon-like peptide-1 receptor antagonist exendin(9-39).胰高血糖素样肽-1受体拮抗剂艾塞那肽(9-39)的天然形式和体外糖基化形式的特性
Metabolism. 1999 Jun;48(6):716-24. doi: 10.1016/s0026-0495(99)90170-1.
6
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.肠促胰岛素(GIP和GLP-1)在代谢性疾病和心血管疾病中的演变历程:病理生理学最新进展
Diabetes Obes Metab. 2021 Sep;23 Suppl 3:5-29. doi: 10.1111/dom.14496.
7
Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.胰高血糖素样肽1和胃抑制性多肽:在2型糖尿病中的潜在应用
BioDrugs. 2003;17(2):93-102. doi: 10.2165/00063030-200317020-00002.
8
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.肠促胰岛素途径在 2 型糖尿病发病机制中的作用。
Cleve Clin J Med. 2009 Dec;76 Suppl 5:S12-9. doi: 10.3949/ccjm.76.s5.03.
9
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.一种 DPP-IV 抗性三重作用激动剂,作用于 GIP、GLP-1 和胰高血糖素受体,在高脂肪饮食喂养的小鼠中具有强效的降血糖和胰岛素促分泌作用。
Diabetologia. 2013 Jun;56(6):1417-24. doi: 10.1007/s00125-013-2892-2. Epub 2013 Mar 17.
10
Incretin hormones: Their role in health and disease.肠降血糖素:它们在健康和疾病中的作用。
Diabetes Obes Metab. 2018 Feb;20 Suppl 1:5-21. doi: 10.1111/dom.13129.

引用本文的文献

1
Enhancement of Adhesion Characteristics of Low-Density Polyethylene Using Atmospheric Plasma Initiated-Grafting of Polyethylene Glycol.利用常压等离子体引发聚乙二醇接枝增强低密度聚乙烯的粘附特性
Polymers (Basel). 2021 Apr 16;13(8):1309. doi: 10.3390/polym13081309.
2
Nanostructure-Enabled and Macromolecule-Grafted Surfaces for Biomedical Applications.用于生物医学应用的纳米结构与大分子接枝表面
Micromachines (Basel). 2018 May 17;9(5):243. doi: 10.3390/mi9050243.
3
Enhanced Incretin Effects of Exendin-4 Expressing Chimeric Plasmid Based On Two-Step Transcription Amplification System with Dendritic Bioreducible Polymer for the Treatment of Type 2 Diabetes.

本文引用的文献

1
Prolonged Remission of Diabetes by Regeneration of β Cells in Diabetic Mice Treated with Recombinant Adenoviral Vector Expressing Glucagon-like Peptide-1.用表达胰高血糖素样肽-1的重组腺病毒载体治疗的糖尿病小鼠中,β细胞再生实现糖尿病的长期缓解
Mol Ther. 2007 Jan;15(1):86-93. doi: 10.1038/sj.mt.6300005. Epub 2016 Dec 8.
2
Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.采用精氨酸接枝的生物还原聚合物系统进行促红细胞生成素基因传递。
J Control Release. 2012 Feb 10;157(3):437-44. doi: 10.1016/j.jconrel.2011.10.014. Epub 2011 Oct 20.
3
Polymeric gene delivery for diabetic treatment.
基于具有树枝状生物可还原聚合物的两步转录扩增系统的艾塞那肽-4表达嵌合质粒增强肠促胰岛素效应用于2型糖尿病的治疗
J Gene Ther. 2013 Dec 1;1(1):7-15.
4
Bioreducible polymers for therapeutic gene delivery.用于治疗性基因递送的可生物还原聚合物。
J Control Release. 2014 Sep 28;190:424-39. doi: 10.1016/j.jconrel.2014.04.012. Epub 2014 Apr 16.
5
A review of polymeric refabrication techniques to modify polymer properties for biomedical and drug delivery applications.用于生物医学和药物输送应用的聚合物改性的聚合再制造技术综述。
AAPS PharmSciTech. 2013 Jun;14(2):692-711. doi: 10.1208/s12249-013-9955-z. Epub 2013 Mar 30.
聚合物基因传递治疗糖尿病。
Diabetes Metab J. 2011 Aug;35(4):317-26. doi: 10.4093/dmj.2011.35.4.317. Epub 2011 Aug 31.
4
Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymer.利用两步转录扩增质粒系统,结合分泌信号肽和精氨酸接枝的生物可还原聚合物,实现高效 GLP-1 基因传递。
J Control Release. 2012 Jan 30;157(2):243-8. doi: 10.1016/j.jconrel.2011.09.072. Epub 2011 Sep 16.
5
Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration.通过系统给药实现肝癌特异性治疗的生物可还原聚合物偶联溶瘤腺病毒。
Biomaterials. 2011 Dec;32(35):9328-42. doi: 10.1016/j.biomaterials.2011.08.066. Epub 2011 Sep 16.
6
Cellular glucose availability and glucagon-like peptide-1.细胞葡萄糖供应与胰高血糖素样肽-1。
Prog Biophys Mol Biol. 2011 Nov;107(2):286-92. doi: 10.1016/j.pbiomolbio.2011.08.009. Epub 2011 Sep 3.
7
The future of incretin-based therapy: novel avenues--novel targets.基于肠促胰岛素治疗的未来:新途径-新靶点。
Diabetes Obes Metab. 2011 Oct;13 Suppl 1:158-66. doi: 10.1111/j.1463-1326.2011.01457.x.
8
Glucagon-like peptide-1 gene therapy.胰高血糖素样肽-1基因疗法。
Exp Diabetes Res. 2011;2011:601047. doi: 10.1155/2011/601047. Epub 2011 Jun 20.
9
Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.病毒基因组 DNA/脂质体通过全身给药引发原位溶瘤病毒复制和强大的抗肿瘤疗效。
J Control Release. 2011 Oct 30;155(2):317-25. doi: 10.1016/j.jconrel.2011.06.014. Epub 2011 Jun 14.
10
In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.通过靶向 GLP-1 受体对移植胰岛进行 64Cu-DO3A-VS-Cys40-Exendin-4 的体内成像。
Bioconjug Chem. 2011 Aug 17;22(8):1587-94. doi: 10.1021/bc200132t. Epub 2011 Jul 14.